Peter Joseph Pappas Research Grants
Forecasted
Peter Joseph Pappas Research Grants support researchers studying severe preeclampsia and related pregnancy disorders to eliminate preterm delivery as the primary intervention by 2050.
Funder: Preeclampsia Foundation
Due Dates (Anticipated): August 2027 (Letter of Intent) | September 2027 (Full application)
Funding Amounts: $50,000–$100,000 per two-year project; up to $200,000 total annually
Summary: Supports research to eliminate preterm delivery as the primary intervention for severe preeclampsia, HELLP syndrome, and related hypertensive pregnancy disorders.
Key Information: PIs must hold faculty appointments at accredited universities or bona fide research centers; trainees cannot apply as PIs.
Description
The Peter Joseph Pappas Research Grants program is administered by the Preeclampsia Foundation and named for the infant son of Lauren and Clement Pappas. Its ultimate goal is to eliminate preterm delivery as the primary intervention for severe preeclampsia, HELLP syndrome, and related hypertensive disorders of pregnancy by 2050.
Supported research includes understanding disease pathways and subtypes, improving diagnosis and prediction of severe disease, developing therapies to halt or reverse placental and organ dysfunction, and improving preconception and inter-conception health. Applicants should address research gaps identified through the 2020 workshop jointly sponsored by the Foundation and the Society for Maternal-Fetal Medicine. Registry use is not mandatory, but preference goes to projects using or building upon Preeclampsia Registry data, or contributing patient-specific data or biological materials to its repository.
